Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | AHR | P35869 | 6/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | IDO1 | P14902 | 1/20 | 0.32 |
| ▸ | NOTUM | Q6P988 | 3/20 | 0.31 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | PNMT | P11086 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11453837 | 0.85 | TSHR (0.39) | CYP3A4MAPK1AHRTDP1CYP2A6 | |
| SCHEMBL348089 | 0.79 | CYP3A4 (0.62) | CYP3A4MAPK1AHRTDP1CYP2A6 | |
| SCHEMBL29368277 | 0.79 | CYP3A4 (0.62) | CYP3A4MAPK1AHRTDP1CYP2A6 | |
| SCHEMBL30354095 | 0.79 | CYP3A4 (0.38) | CYP3A4MAPK1AHRTDP1CYP2A6 | |
| SCHEMBL4357969 | 0.79 | CYP3A4 (0.38) | CYP3A4MAPK1AHRTDP1CYP2A6 | |
| SCHEMBL30435783 | 0.79 | CYP3A4 (0.38) | CYP3A4MAPK1AHRTDP1CYP2A6 | |
| Methane SCHEMBL23466796 | 0.75 | CYP3A4 (0.59) | CYP3A4MAPK1AHRTDP1CYP2A6 | |
| SCHEMBL16556080 | 0.75 | — | — | |
| SCHEMBL11681212 | 0.75 | CYP3A4 (0.35) | CYP3A4MAPK1AHRCYP2A6TSHR | |
| SCHEMBL16555630 | 0.75 | ALDH1A1 (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109337132-A | A kind of free from extraneous odour NR material prescription and preparation method thereof | 安徽龙川橡塑科技有限公司 | 2019-02-15 | — | — | CN | claimed |
| EP-3194414-A1 | METHODS FOR THE PREPARATION OF DIASTEREOMERICALLY PURE PHOSPHORAMIDATE PRODRUGS | MEDIVIR AB (SE) | 2017-07-26 | — | — | EP | claimed |
| CN-106833406-A | A kind of high refractive index nano inorganic matter hydridization photovoltaic encapsulation material | 杭州福斯特光伏材料股份有限公司 | 2017-06-13 | — | — | CN | claimed |
| WO-2016041877-A1 | METHODS FOR THE PREPARATION OF DIASTEREOMERICALLY PURE PHOSPHORAMIDATE PRODRUGS | MEDIVIR AB (SE) | 2016-03-24 | — | — | WO | claimed |
| US-8198378-B2 | Aromatic organosulfur functionalized 1,4-cis polybutadiene | KOREA KUMHO PETROCHEMICAL CO., LTD. (KR) | 2012-06-12 | — | — | US | claimed |
| US-20110136956-A1 | 1,4-CIS-POLYBUTADIENE FUNCTIONALIZED WITH ORGANOSULFUR COMPOUND FOR PREPARATION OF GOLF BALL CORE | KOREA KUMHO PETROCHEMICAL CO., LTD. (KR) | 2011-06-09 | — | — | US | claimed |
| US-20090156751-A1 | Aromatic Organosulfur Functionalized 1,4-cis Polybutadiene | KOREA KUMHO PETROCHEMICAL CO., LTD. (KR) | 2009-06-18 | — | — | US | claimed |
| CN-1169661-C | Process for directly producing active rubber powder with waste rubber | 刘扬生 | 2004-10-06 | — | — | CN | claimed |
| CN-1392037-A | Process for directly producing active rubber powder with waste rubber | LIU YANGSHENG (CN) | 2003-01-22 | — | — | CN | claimed |
| US-3939056-A | Coated plating rack | SONY CORPORATION (JA) | 1976-02-17 | — | — | US | claimed |
| EP-2841429-B1 | TETRAZOLINONE COMPOUNDS AND ITS USE AS PESTICIDES | SUMITOMO CHEMICAL CO (JP) | 2020-10-21 | — | — | EP | disclosed |
| CN-109337132-A | A kind of free from extraneous odour NR material prescription and preparation method thereof | 安徽龙川橡塑科技有限公司 | 2019-02-15 | — | — | CN | disclosed |
| US-10118941-B2 | Methods for the preparation of diastereomerically pure phosphoramidate prodrugs | MEDIVIR AB (SE) | 2018-11-06 | — | — | US | disclosed |
| EP-2826826-B1 | COMPOSITION FOR FORMING A COATING TYPE BPSG FILM, SUBSTRATE FORMED A FILM BY SAID COMPOSITION, AND PATTERNING PROCESS USING SAID COMPOSITION | SHINETSU CHEMICAL CO (JP) | 2018-08-01 | — | — | EP | disclosed |
| US-20170275322-A1 | METHODS FOR THE PREPARATION OF DIASTEREOMERICALLY PURE PHOSPHORAMIDATE PRODRUGS | MEDIVIR AB (SE) | 2017-09-28 | — | — | US | disclosed |
| US-4172944-A | Water insoluble styryl dyestuffs having hetero-aryl methylene substituent | BAYER AKTIENGESELLSCHAFT (DE) | 1979-10-30 | — | — | US | disclosed |
| US-4016191-A | WATER INSOLUBLE; LIGHTFASTNESS | BAYER AKTIENGESELLSCHAFT (DT) | 1977-04-05 | — | — | US | disclosed |
| US-3998866-A | PESTICIDES, POST-EMERGENCE HERBICIDES AND POLYMER INTERMEDIATES | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1976-12-21 | — | — | US | disclosed |
| US-3966769-A | Sulfonyl compounds | CASSELLA FARBWERKE MAINKUR AKTIENGESELLSCHAFT (DT) | 1976-06-29 | — | — | US | disclosed |
| US-3939056-A | Coated plating rack | SONY CORPORATION (JA) | 1976-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170275322-A1 | METHODS FOR THE PREPARATION OF DIASTEREOMERICALLY PURE PHOSPHORAMIDATE PRODRUGS | PNP, PAICS, NUDT1 | CYP3A4 328/4885MAPK1 2963/4885AHR 3402/4885 |
| US-10118941-B2 | Methods for the preparation of diastereomerically pure phosphoramidate prodrugs | PNP, PAICS, NUDT1 | CYP3A4 328/4885MAPK1 2963/4885AHR 3402/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.